Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F15%3A00452769" target="_blank" >RIV/61388971:_____/15:00452769 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.immuni.2015.04.015" target="_blank" >http://dx.doi.org/10.1016/j.immuni.2015.04.015</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.immuni.2015.04.015" target="_blank" >10.1016/j.immuni.2015.04.015</a>
Alternative languages
Result language
angličtina
Original language name
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
Original language description
Interleukin-2 (IL-2) is a pleiotropic cytokine that regulates immune cell homeostasis and has been used to treat a range of disorders including cancer and autoimmune disease. IL-2 signals via interleukin-2 receptor-beta (IL-2R beta):IL-2R gamma heterodimers on cells expressing high (regulatory T cells, Treg) or low (effector cells) amounts of IL-2R alpha (CD25). When complexed with IL-2, certain anti-cytokine antibodies preferentially stimulate expansion of Treg (JES6-1) or effector (S4B6) cells, offering a strategy for targeted disease therapy. We found that JES6-1 sterically blocked the IL-2:IL-2R beta and IL-2:IL-2Rg interactions, but also allosterically lowered the IL-2:IL-2R alpha affinity through a "triggered exchange'' mechanism favoring IL-2R alpha hi Treg cells, creating a positive feedback loop for IL-2R alpha hi cell activation. Conversely, S4B6 sterically blocked the IL-2:IL-2R alpha interaction, while also conformationally stabilizing the IL-2:IL-2R beta interaction, thus
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Immunity
ISSN
1074-7613
e-ISSN
—
Volume of the periodical
42
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
11
Pages from-to
815-825
UT code for WoS article
000354827400009
EID of the result in the Scopus database
—